Rocket Lab drops 7% after Nasdaq-100 entry, sets launch record
Rocket Lab shares declined 6.75% to $88.71 following Nasdaq-100 inclusion and SpaceX's IPO. The company set a record launch time with the VICTUS HAZE mission. Analysts maintain bullish targets with revenue expected to reach $915 million this year.

*this image is generated using AI for illustrative purposes only.
Rocket Lab Corporation (NASDAQ: RKLB) shares fell 6.75% to $88.71 on Wednesday, extending losses as investors adjust to the stock's recent addition to the Nasdaq-100 Index and shifting market capital following SpaceX's IPO. The decline comes despite the inclusion forcing index-tracking funds like the Invesco QQQ, which manages over $300 billion in assets, to hold the stock. While the long-term structure remains constructive, the stock is now trading 23.6% below its 20-day SMA and 17.1% below its 50-day SMA, signaling a sharp pullback from recent highs.
Operational Milestones
Rocket Lab launched the U.S. Space Force’s VICTUS HAZE mission late Monday, lifting off just 16 hours and 42 minutes after receiving the official Notice to Launch. This achievement shattered the previous record by more than 10 hours. The company managed all operational phases, providing end-to-end space services including spacecraft design, component fabrication, launch, and 24/7 on-orbit management. The deployed Pioneer spacecraft is fully commissioned and conducting Rendezvous and Proximity Operations (RPO) to track another active spacecraft in low Earth orbit.
Financial and Technical Analysis
Recent data indicates revenue rose by 63% to $200 million, driven by Electron launches. The company booked 31 missions, with HASTE, its supersonic solution for the Department of Defense, accounting for a third of its backlog. Analysts expect annual revenue to jump by 52% this year to $915 million, followed by $1.2 billion next year. Rocket Lab's backlog exceeds $2.2 billion.
| Metric | Value |
|---|---|
| Current Price | $88.71 |
| 52-Week Performance | +161.57% |
| 200-day SMA | $74.54 |
| 20-day SMA | $114.42 |
| 50-day SMA | $105.46 |
Technically, the stock remains in a bullish long-term structure, trading 17.3% above its 200-day SMA. However, near-term momentum is fading, with the MACD below its signal line. Key resistance sits at $93.00, while support is located near $74.00.
Analyst Optimism and Forecasts
Analysts predict a rebound driven by strong backlog growth and NASA acceleration. KeyBanc upgraded Rocket Lab to Overweight with a $135 price target, calling it the "clear #2 to SpaceX." KeyCorp’s Michael Leshock boosted his target to $135, while Stifel Nicolaus’ Eric Rasmussen hiked his target to $132. New Street pushed its target to $150, and other analysts from Deutsche Bank, Needham, and Cowen have targets of $120.
How will the completion of the VICTUS HAZE mission impact Rocket Lab's ability to secure additional high-priority defense contracts?
Can Rocket Lab sustain its projected 52% revenue growth despite the current bearish technical momentum and market volatility?
What effect will SpaceX's IPO have on Rocket Lab's market share and competitive positioning in the commercial launch sector?





























